BAX is expected to report earnings to rise 14.24% to 77 cents per share on October 24
Q3'24
Est.
$0.78
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.04
Q4'23
Beat
by $0.02
Q3'23
Beat
by $0.01
The last earnings report on August 06 showed earnings per share of 68 cents, beating the estimate of 66 cents. With 2.66M shares outstanding, the current market capitalization sits at 21.77B.
a provider of a portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices